BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26025445)

  • 1. Diagnostic and prognostic utility of tissue factor for severe sepsis and sepsis-induced acute lung injury.
    Xue M; Sun Z; Shao M; Yin J; Deng Z; Zhang J; Xing L; Yang X; Chen B; Dong Z; Han Y; Sun S; Wang Y; Yao C; Chu X; Tong C; Song Z
    J Transl Med; 2015 May; 13():172. PubMed ID: 26025445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients.
    Gando S; Kameue T; Matsuda N; Hayakawa M; Morimoto Y; Ishitani T; Kemmotsu O
    Thromb Res; 2003 Jan; 109(2-3):119-24. PubMed ID: 12706640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients.
    Jabaudon M; Futier E; Roszyk L; Chalus E; Guerin R; Petit A; Mrozek S; Perbet S; Cayot-Constantin S; Chartier C; Sapin V; Bazin JE; Constantin JM
    Crit Care Med; 2011 Mar; 39(3):480-8. PubMed ID: 21220996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Value of Plasma MicroRNA-155 and MicroRNA-146a Level in Severe Sepsis and Sepsis-Induced Acute Lung Injury Patients.
    Han Y; Li Y; Jiang Y
    Clin Lab; 2016 Dec; 62(12):2355-2360. PubMed ID: 28164567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of procalcitonin and IL-6 in discriminating between septic and non-septic causes of ALI/ARDS: a prospective observational study.
    Tsantes A; Tsangaris I; Kopterides P; Kapsimali V; Antonakos G; Zerva A; Kalamara E; Bonovas S; Tsaknis G; Vrigou E; Maniatis N; Dima K; Armaganidis A
    Clin Chem Lab Med; 2013 Jul; 51(7):1535-42. PubMed ID: 23314554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis.
    Sabharwal AK; Bajaj SP; Ameri A; Tricomi SM; Hyers TM; Dahms TE; Taylor FB; Bajaj MS
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):758-67. PubMed ID: 7881667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic values of serum activin-a levels in patients with acute respiratory distress syndrome.
    Kim JM; Lee JK; Choi SM; Lee J; Park YS; Lee CH; Yim JJ; Yoo CG; Kim YW; Han SK; Lee SM
    BMC Pulm Med; 2019 Jun; 19(1):115. PubMed ID: 31238942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of a model based on PIRO conception in predicting the prognosis in critical patients].
    Wang T; Cui YL; Chu ZX; Liu J; Ban Y; Li TS
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Dec; 25(12):729-33. PubMed ID: 24447353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic utility of changes in N-terminal pro-brain natriuretic Peptide combined with sequential organ failure assessment scores in patients with acute lung injury/acute respiratory distress syndrome concomitant with septic shock.
    Park BH; Park MS; Kim YS; Kim SK; Kang YA; Jung JY; Lim JE; Kim EY; Chang J
    Shock; 2011 Aug; 36(2):109-14. PubMed ID: 21478812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis.
    Gando S; Nanzaki S; Morimoto Y; Kobayashi S; Kemmotsu O
    J Trauma; 1999 Oct; 47(4):719-23. PubMed ID: 10528607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic peptide proANP (1-98), a biomarker of ALI/ARDS in burns.
    Tokarik M; Sjöberg F; Vajtr D; Broz L; Balik M; Vranova J
    Burns; 2013 Mar; 39(2):243-8. PubMed ID: 23006832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis.
    Gando S; Kameue T; Morimoto Y; Matsuda N; Hayakawa M; Kemmotsu O
    Crit Care Med; 2002 Aug; 30(8):1729-34. PubMed ID: 12163784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury.
    Ware LB; Eisner MD; Thompson BT; Parsons PE; Matthay MA
    Am J Respir Crit Care Med; 2004 Oct; 170(7):766-72. PubMed ID: 15201135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of soluble thrombomodulin in the risk stratification and prognosis evaluation of septic patients in the emergency department.
    Yin Q; Liu B; Chen Y; Zhao Y; Li C
    Thromb Res; 2013 Oct; 132(4):471-6. PubMed ID: 24035044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients.
    van der Heijden M; van Nieuw Amerongen GP; Koolwijk P; van Hinsbergh VW; Groeneveld AB
    Thorax; 2008 Oct; 63(10):903-9. PubMed ID: 18559364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum MMP-8 and TIMP-1 in critically ill patients with acute respiratory failure: TIMP-1 is associated with increased 90-day mortality.
    Hästbacka J; Linko R; Tervahartiala T; Varpula T; Hovilehto S; Parviainen I; Vaara ST; Sorsa T; Pettilä V
    Anesth Analg; 2014 Apr; 118(4):790-8. PubMed ID: 24651234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Plasma Levels of Adiponectin Do Not Explain Acute Respiratory Distress Syndrome Risk: a Prospective Cohort Study of Patients with Severe Sepsis.
    Palakshappa JA; Anderson BJ; Reilly JP; Shashaty MG; Ueno R; Wu Q; Ittner CA; Tommasini A; Dunn TG; Charles D; Kazi A; Christie JD; Meyer NJ
    Crit Care; 2016 Mar; 20():71. PubMed ID: 26984771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of circulating long non-coding RNA maternally expressed gene 3 as a predictor of higher acute respiratory distress syndrome risk and 28-day mortality in sepsis patients.
    Wu X; Chen D; Yu L
    J Clin Lab Anal; 2020 Nov; 34(11):e23488. PubMed ID: 32844492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor.
    Bastarache JA; Wang L; Geiser T; Wang Z; Albertine KH; Matthay MA; Ware LB
    Thorax; 2007 Jul; 62(7):608-16. PubMed ID: 17356058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.